Tonix Pharmaceuticals Holding (TNXP) Total Current Liabilities (2023 - 2025)
Historic Total Current Liabilities for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $21.0 million.
- Tonix Pharmaceuticals Holding's Total Current Liabilities rose 3853.5% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 3853.5%. This contributed to the annual value of $18.3 million for FY2024, which is 305.55% down from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Total Current Liabilities stood at $21.0 million for Q3 2025, which was up 3853.5% from $19.1 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Total Current Liabilities high stood at $22.0 million for Q2 2024, and its period low was $12.1 million during Q1 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's median Total Current Liabilities value was $18.4 million (recorded in 2023), while the average stood at $17.9 million.
- In the last 5 years, Tonix Pharmaceuticals Holding's Total Current Liabilities soared by 5665.11% in 2024 and then plummeted by 4069.05% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Total Current Liabilities (Quarter) stood at $18.9 million in 2023, then fell by 3.06% to $18.3 million in 2024, then increased by 14.88% to $21.0 million in 2025.
- Its Total Current Liabilities stands at $21.0 million for Q3 2025, versus $19.1 million for Q2 2025 and $12.1 million for Q1 2025.